» Articles » PMID: 11050079

ETL, a Novel Seven-transmembrane Receptor That is Developmentally Regulated in the Heart. ETL is a Member of the Secretin Family and Belongs to the Epidermal Growth Factor-seven-transmembrane Subfamily

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2000 Oct 26
PMID 11050079
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Using differential display of rat fetal and postnatal cardiomyocytes, we have identified a novel seven-transmembrane receptor, ETL. The cDNA-predicted amino acid sequence of ETL indicated that it encodes a 738-aa protein composed of a large extracellular domain with epidermal growth factor (EGF)-like repeats, a seven-transmembrane domain, and a short cytoplasmic tail. ETL belongs to the secretin family of G-protein-coupled peptide hormone receptors and the EGF-TM7 subfamily of receptors. The latter are characterized by a variable number of extracellular EGF and cell surface domains and conserved seven transmembrane-spanning regions. ETL mRNA expression is up-regulated in the adult rat and human heart. In situ hybridization analyses revealed expression in rat cardiomyocytes and abundant expression in vascular and bronchiolar smooth muscle cells. In COS-7 cells transfected with Myc-tagged rat ETL, rat ETL exists as a stable dimer and undergoes endoproteolytic cleavage of the extracellular domain. The proteolytic activity can be abolished by a specific mutation, T455A, in this domain. In transfected mammalian cells, ETL is associated with cell membranes and is also observed in cytoplasmic vesicles. ETL is the first seven-transmembrane receptor containing EGF-like repeats that is developmentally regulated in the heart.

Citing Articles

ELTD1 is present in extracellular vesicles derived from endothelial cells as a cleaved extracellular domain which induces in vivo angiogenesis.

Sheldon H, Zhang W, Bridges E, Ang K, Lin S, Masiero M J Extracell Biol. 2024; 1(8):e52.

PMID: 38939053 PMC: 11080856. DOI: 10.1002/jex2.52.


ADGRL4 Promotes Cell Growth, Aggressiveness, EMT, and Angiogenesis in Neuroblastoma via Activation of ERK/STAT3 Pathway.

Geng G, Zhang L, Yu Y, Guo X, Li Q, Ming M Curr Mol Med. 2024; 25(1):45-55.

PMID: 38178660 DOI: 10.2174/0115665240254765231117122210.


Adhesion G protein-coupled receptor gluing action guides tissue development and disease.

Sreepada A, Tiwari M, Pal K J Mol Med (Berl). 2022; 100(10):1355-1372.

PMID: 35969283 DOI: 10.1007/s00109-022-02240-0.


ELTD1 as a multi-focal target for malignant gliomas: preclinical studies.

Zalles M, Smith N, Saunders D, Guzman M, Lerner M, Fung K Neurooncol Adv. 2021; 3(1):vdab132.

PMID: 34704036 PMC: 8541707. DOI: 10.1093/noajnl/vdab132.


ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype.

Sheldon H, Alexander J, Bridges E, Moreira L, Reilly S, Ang K Int J Mol Sci. 2021; 22(20).

PMID: 34681953 PMC: 8539764. DOI: 10.3390/ijms222011293.